In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had a fascinating conversation with Michelle Werner, CEO of Alltrna and CEO/Partner at Fla...
Continue reading
To fully harness the potential of genomics for early detection and prevention in at-risk populations, a comprehensive and strategic approach is crucial. Below, ...
Continue reading
Genomics has come a long way since the first human genome was sequenced in 2003. Today, sequencing a genome is not only faster but also significantly more affor...
Continue reading
Natural history studies are vital for understanding disease progression, particularly in rare diseases. They provide a baseline to evaluate the effectiveness of...
Continue reading
Children born with rare inherited conditions often face a protracted diagnostic odyssey before the cause of their illness is identified. This delay is costly, s...
Continue reading
In the informative webinar hosted by Dr. Patrick Short, Co-founder and CEO of Sano Genetics, guest Dr. Andrea Gropman explored the profound impact of genetics a...
Continue reading
Liver disease remains one of the leading causes of morbidity and mortality worldwide, presenting complex challenges in healthcare due to its multifaceted nature...
Continue reading
Many hereditary diseases are clinically manageable when detected early, yet most carriers are identified only after symptoms appear. Population genomic screenin...
Continue reading
Precision medicine represents a fundamental shift in how treatments are developed and delivered. Rather than relying on population-level assumptions about how p...
Continue reading
Last year, Sano CEO Dr. Patrick Short presented a webinar called “Genetics Essentials for Clinical Research professionals.” In it, he explained the fundamentals...
Continue reading